EP0974366B1

Oral pharmaceutical preparations decreased in bitterness by masking

Abstract

This record has no abstract on file.

EP0974366B1, drawing sheet 1
Sheet 1 of 4

Term

Term ended

Expired 26 March 2018, 8.5 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

8 claims: 3 independent, 5 dependent

  1. 1
    A pharmaceutical composition for oral administration comprising a basic medicine and an anionic acidic polysaccharide selected from carrageenan, chondroitin sulfate, dextran sulfate, alginic acid, gellan gum and xanthan gum, the basic medicine on its own having an unpleasant taste, the basic medicine and polysaccharide interacting to reduce the unpleasant taste by decreasing the bonding rate of the basic medicine to taste receptors, wherein the basic medicine is ticlopidine hydrochloride, maprotiline hydrochloride, iphenprodil tartrate, berberine hydrochloride, digitoxin, sulpyrine, azelastine hydrochloride, etilefrine hydrochloride, diltiazem hydrochloride, propranolol hydrochloride, chloramphenicol, aminophylline, erythromycin, phenobarbital, calcium pantothenic acid, indeloxazine hydrochloride, aminoguanidine hydrochloride, donepezil hydrochloride, (RS) -1- (isopropoxycarbonyloxy)ethyl(+) - (6R, 7R) -7{(z) - 2 - (2 - aminothiazole - 4 -yl)-2 - hydroxyiminoacetamide}-3 - N, N - dimethylcarbamoyloxymethyl - 8 - oxo - 5 - thia-1 - azabicyclo [4.2.0] octo - 2 - en - 2 - carboxylate hydrochloride salt or cefcapene hydrochloride.
  2. 4
    A pharmaceutical composition according to any preceding Claim, wherein the anionic acidic polysaccharide is contained in an amount of 0.1 to 20 parts by weight with respect to 1 part by weight of the basic medicine.
  3. 7
    A method for reducing the unpleasant taste of a basic medicine which comprises the step of blending an anionic acidic polymer selected from carrageenan, chondroitin sulfate, dextran sulfate, alginic acid, gellan gum and xanthan gum with a basic medicine, the basic medicine in isolation having an unpleasant taste, the basic medicine and polysaccharide interacting to reduce the unpleasant taste by decreasing the bonding rate of the basic medicine to taste receptors, wherein the basic medicine is ticlopidine hydrochloride, maprotiline hydrochloride, iphenprodil tertrate, berberine hydrochloride, digitoxin, sulpyrine, azelastine hydrochloride, etilefrine hydrochloride, diltiazem hydrochloride, propranolol hydrochloride, chloramphenicol, aminophylline, erythromycin, phenobarbital, calcium pantothenic acid, indeloxazine hydrochloride, aminoguanidine hydrochloride, donepezil hydrochloride, (RS) -1- (isopropoxycarbonyloxy)ethyl(+) - (6R, 7R) -7{(z) - 2 - (2 - aminothiazole - 4 -yl) - 2 - hydroxyiminoacetamide}-3 - N, N - dimethylcarbamoyloxymethyl - 8 - oxo - 5 - thia-1 - azabicyclo [4.2.0] octo - 2 - en - 2 - carboxylate hydrochloride salt or cefcapene hydrochloride.